Karuna Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
KRTX, Karuna Therapeutics, will participate in the Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 2:40 p.m. EST. This fireside chat will showcase insights from senior management on Karuna's mission to develop transformative therapies for neuropsychiatric disorders. Interested investors can watch the live webcast on the Investor Relations page of Karuna’s website, with a replay available for 90 days following the event. Karuna is focused on advancing treatment standards for CNS disorders, striving to improve the lives of affected individuals.
- None.
- None.
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders, today announced that senior management will participate in a fireside chat at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17, 2020 at 2:40 p.m. EST.
A live webcast of the fireside chat will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 90 days on Karuna’s website following the conference.
About Karuna
Karuna is a clinical-stage biopharmaceutical company committed to developing and delivering first-in-class therapies with the potential to transform the lives of people with CNS disorders – which remain among the most disabling and potentially fatal disorders worldwide. Galvanized by the understanding that today’s neuropsychiatric patients deserve better, Karuna’s mission is to harness the untapped potential of the brain’s complex biology in pursuit of novel therapeutic pathways that will advance the standard of care. For more information, please visit karunatx.com.
